Quantitative measurements of tumoral p95HER2 protein expression in metastatic breast cancer patients treated with trastuzumab: independent validation of the p95HER2 clinical cutoff (Q46058629)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Quantitative measurements of tumoral p95HER2 protein expression in metastatic breast cancer patients treated with trastuzumab: independent validation of the p95HER2 clinical cutoff |
scientific article |
Statements
1 reference
Quantitative measurements of tumoral p95HER2 protein expression in metastatic breast cancer patients treated with trastuzumab: independent validation of the p95HER2 clinical cutoff (English)
1 reference
Jacek Jassem
1 reference
Wojciech Biernat
1 reference
Renata Duchnowska
1 reference
Bogumiła Czartoryska-Arłukowicz
1 reference
Dorota Zuziak
1 reference
Jodi M Weidler
1 reference
Jeff Sperinde
1 reference
Mojgan Haddad
1 reference
Ahmed Chenna
1 reference
Agnes Paquet
1 reference
Yolanda Lie
1 reference
Weidong Huang
1 reference
John Winslow
1 reference
Tomasz Jankowski
1 reference
Małgorzata Foszczyńska-Kłoda
1 reference
Barbara Radecka
1 reference
Jolanta Zok
1 reference
Michał Wiśniewski
1 reference
25 March 2014
1 reference
1 reference
20
1 reference
10
1 reference
2805-2813
1 reference
Identifiers
1 reference
1 reference